Beijing, China

Shiyou Li

This inventor holds 1 USPTO granted patent. Top assignee: Beijing Tricisionbio Therapeutics Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shiyou Li. Retrieved from https://idiyas.com/inventor/shiyou-li-n7fhdbpf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shiyou Li: Innovator in Nucleic Acid Delivery

Introduction

Shiyou Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of lipid compounds for therapeutic applications. His innovative work focuses on enhancing the delivery of nucleic acids, which are crucial for various medical treatments.

Latest Patents

Shiyou Li holds a patent for a lipid compound and its use in the delivery of nucleic acids. The patent describes an ionizable lipid compound featuring an adjacent cis-double bond structure. This compound is designed to improve the encapsulation rate of active substances and enhance cell or in vivo transfection rates. It is particularly effective for preparing nanoparticles with a solid structure, making it a valuable asset in therapeutic delivery systems.

Career Highlights

Shiyou Li is associated with Beijing Tricisionbio Therapeutics Inc., where he applies his expertise in lipid chemistry to advance therapeutic technologies. His work has positioned him as a key figure in the development of innovative solutions for drug delivery.

Collaborations

Shiyou Li collaborates with notable colleagues, including Yaoxin Lin and Chengqiang Gao. These partnerships enhance the research and development efforts at Tricisionbio Therapeutics, fostering a collaborative environment for innovation.

Conclusion

Shiyou Li's contributions to the field of nucleic acid delivery through his innovative lipid compounds demonstrate his commitment to advancing biotechnology. His work not only holds promise for improved therapeutic outcomes but also showcases the importance of collaboration in scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…